PP
The Meet Kevin Pricing Power ETF
stockNYSE

People get confused because he seemingly manic posts, and I think some of that energy comes from PP thinking that HE is going to make it i.e. if he posts hard and crazy enough some Higher Level Grifter will once again reach down and this time place him properly in the stratosphere; a big beautiful Star of Grift, and it's only a matter of time. His followers though are just grist for the mill. There's no WAGMI in the PP Seeds Art Coin.

PP believes in none of this. He doesn't even really have any theories of his own, just agrees with whatever chat or his guests says. Even his pivot to Christianity is fake. He got cornered on one of his lies and rather than respond he started pretending people were attacking his faith. He is a conman through and through.

I think PP has been high on his own supply for a long, long time.

Not to mention, beyond the fascinating horrors of the human psyche, I think there's also a collective hope here that maybe, just maybe, publicly mocking people like Marantz and PP will help someone not fall into the grift they're pushing.

You just know that irl PP tries to tell people he's got a close personal friend in the Trump administration.

Ohhh PP can 'feel it.' God, it's wretched. About the only thing worse than being this chode is being someone whose only hope is believing in him.

I realize he's a scammer but I also think deep down PP honestly believes this shit at this point He's faced with a life of, well, basically nothing once this peters out so he's probably convinced himself this will actually be his ticket to freedom even if the scam dries up

I cut out sugar for 3 weeks. I can see my PP again

Which "dude" are you referring to? Ploot, ag47 or PP Pants?

this dude is PP? or Pulte?

**TL;DR:** Nu Skin trades at a \~$234M market cap with $251.8M of net working capital, $379.6M of PP&E, and essentially zero net debt. You’re getting the real estate, the factories, and the brand for less than free. There’s an unfilled daily gap from Feb 13 up to $9.78 — which is *still* a 5% discount to tangible book. Yes it’s an MLM. Yes revenue is falling. **The balance sheet (6/30/26 10-Q, \~48.55M shares out)** * Cash + ST investments: $190.0M — that’s $3.91/share, roughly **81% of the stock price sitting in cash** * Total current assets $508.2M vs total current liabilities $256.4M → **net working capital of $251.8M, or $5.19/share** * Stock is at **$4.82** Stop there for a second. **Net working capital per share ($5.19) is above the share price ($4.82).** Graham-style. Current assets net of *all* current liabilities exceed the entire market cap by \~$18M, and you haven’t counted a single hard asset yet. * PP&E, net: $379.6M ($7.82/share) — the Provo campus, manufacturing, distribution * LT debt: $193.7M against $190.0M cash → **net debt ≈ $4M.** Not levered. Not a bankruptcy candidate. * Total equity $542.7M ($11.18/share). Strip goodwill ($4.8M) and intangibles ($37.9M) → **tangible book $500.1M = $10.30/share** P/B ≈ 0.43. P/TBV ≈ 0.47. P/S ≈ 0.17. It still pays a $0.24 dividend (**\~5.0% yield**) covered by $0.70–$0.90 of guided adjusted EPS. **The chart** Daily gap from Feb 13 remains unfilled up to **$9.78**. The stock has not traded into that zone in eight months. Gap fill from $4.82 = **+103%**. And the punchline: **$9.78 is still 5% below the $10.30 tangible book.** You’d double your money and the thing would *still* be trading at a discount to liquidation-ish value. **The bear case, because I’m not going to pretend it isn’t ugly** 1. **Book value is actively melting.** Equity went $794M → $542.7M in ONE quarter (Q2'26). Goodwill $83.6M → $4.75M — management wrote off 94% of it. If you bought this thesis in April at $7, you got run over by the balance sheet you were underwriting. It can happen again. 2. **Revenue is in structural decline.** Q2'26 revenue $320.1M, **-17.1% YoY**. FY guidance cut from $1.35–1.50B to $1.28–1.35B. EPS guide cut from $0.80–1.20 to $0.70–0.90. This is an MLM: fewer sales leaders → less revenue → fewer sales leaders. It’s reflexive and it does not obviously stop. 3. **The inventory number is the soft spot.** $191.5M of inventory is the biggest chunk of that working capital. It’s skincare and supplements with expiration dates, for a demand base shrinking 17% a year. In any real liquidation you’re haircutting that hard. The $5.19 NWC/share is a book number, not a realizable one. 4. **PP&E is illiquid.** $380M is mostly a purpose-built corporate campus in Utah. Worth book only if someone wants it. 5. **China.** Material revenue exposure to a market with ongoing regulatory and sentiment risk toward direct selling. **What would actually make me wrong (in a good way)** Revenue decline decelerating to single digits. Q3 prints in early November — guidance was $310–340M. A print at the high end with stabilizing sales leader counts is the thing to watch. Not financial advice. I’m a guy on the internet who read a 10-Q.

Big PP Friday

Keine Antwort auf deine Frage, aber ein Hinweis: Ich importiere die PDFs alle in PortfolioPerformance (geht auch als Batch alle mit einmal). Dabei werden auch die Dateinamen in PP als Bemerkung mit abgespeichert. Wenn ich etwas nachschauen möchte, dann gucke ich einfach bei PP und wenn ich dann noch das entsprechende Dokument benötige (meist ist das dann gar nicht mehr nötig), dann habe ich den Dateinamen dort.

My advice for PP is that he should pivot to grifting off people who actually have some money to donate to him.

Credit where it's due: Auxly's operational improvement is real. Q2 revenue grew 18%, adjusted EBITDA grew 24%, and margins improved. The original thesis deserves to be revisited on the fundamentals, not dismissed because it's a cannabis stock.The part I'd revisit is the 20%+ FCF yield.Auxly reported C$13.4M of operating cash flow before working capital changes in Q2, but the actual cash flow statement shows C$2.76M after working capital and roughly C$2.36M after PP&E purchases.For H1, the equivalent FCF calculation is a much stronger C$13.55M, so I wouldn't annualize the weak Q2 in isolation either.There's also a forward looking issue: management expects C$10-12M of capital spending in 2026, versus only C$1.21M of PP&E purchases recorded in H1. Some meaningful investment may still be ahead. And your original C$45M owner earnings estimate against a C$270M market cap implied about a 16.7% yield, before updating the valuation for the subsequent stock appreciation.I think the more useful question is how much normalized annual cash Auxly can generate after working capital needs and the maintenance portion of capex, while separately accounting for growth investments.If that bridge still supports your valuation, it's a stronger thesis than simply annualizing operating cash flow before working capital. The operational progress looks credible; the sustainable owner earnings number is what I'd want to establish next.